Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_assertion type Assertion NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_head.
- NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_assertion description "[New drugs that inhibit the osteoprotegerin (OPG)/receptor activator of NF-?B ligand (RANKL)/RANK pathway have demonstrated efficacy for the treatment of bone metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_provenance.
- NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_assertion evidence source_evidence_literature NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_provenance.
- NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_assertion SIO_000772 23708710 NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_provenance.
- NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_assertion wasDerivedFrom befree-2016 NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_provenance.
- NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_assertion wasGeneratedBy ECO_0000203 NP1080859.RAA7qcZIP8egimgfWyjsO1sF0oTsmub2CgocXuk2SfPhI130_provenance.